NCT01573663

A Drug-Drug Interaction Study of Ambroxol and Levodropropizine

Open Label, Randomized, 3-sequence Crossover Study to Evaluate the Drug-drug Interaction Between Ambroxol HCl and Levodropropizine in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: Male
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the drug-durg interaction between ambroxol and levodropropizine.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Ambroxol and Levodropropizine	Ambroxol HCl 30mg \& Levodropropizine 60mg, PO, Single dose
DRUG	Ambroxol	Ambroxol HCl 30mg, PO, single dose
DRUG	Levodropropizine	Levodropropizine 60mg, PO, single dose

Timeline

• Start date: 2012-02-01
• Primary completion: 2012-04-01
• Completion: 2012-04-01
• First posted: 2012-04-09
• Last updated: 2012-07-19

Locations

1 site across 1 country: South Korea